Cardiva VASCADE Vascular Closure System (VCS)
FDA premarket approval P120016/S026 · decided 2019-02-05
Approval details
- PMA number
- P120016
- Supplement
- S026
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Cardiva VASCADE Vascular Closure System (VCS)
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cardiva Medical, Inc.
- Date received
- 2018-11-23
- Decision date
- 2019-02-05
- Days to decision
- 74 days
- Decision code
- APPR
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Clara, CA
- Statement
- Approval for changing your California headquarters facility to 1615 Wyatt Dr., Santa Clara, California, for the VASCADE Vascular Closure System (VCS) 700-500DX, 70-580I, 800-612C devices.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| CATALYST II AND III (K130124) | Cardiva Medical, Inc. | 2013-03-14 |
| CARDIVA CATALYST III SYSTEM WITH PROTAMINE SULFATE (K082930) | Cardiva Medical, Inc. | 2009-02-13 |
| BOOMERANG CATALYST/BOOMERANG CATALYST II SYSTEM (K072297) | Cardiva Medical, Inc. | 2007-09-12 |
| BOOMERANG WIRE /BOOMERANG PLUS WIRE SYSTEM, MODEL# B PLUS WIRE 58L (K070485) | Cardiva Medical, Inc. | 2007-03-22 |
| BOOMERANG CLOSUREWIRE VASCULAR CLOSURE SYSTEM (K051817) | Cardiva Medical, Inc. | 2006-12-06 |
| BOOMERANG WIRE (K061075) | Cardiva Medical, Inc. | 2006-09-01 |
| VASOSTASIS VASCULAR CLOSURE SYSTEM (K041486) | Cardiva Medical, Inc. | 2004-10-22 |